Abstract:Background: Recent studies have highlighted the significant role of the NF-κB signaling pathway in the initiation and progression of cancer. Furthermore, long noncoding RNAs (lncRNAs) have been identified as pivotal regulators in sustaining the NF-κB signaling pathway's functionality. Despite these findings, the underlying molecular mechanisms through which lncRNAs influence the NF-κB pathway remain largely unexplored. Methods: Bioinformatic analyses were utilized to investigate the differential expression and prognostic significance of XTP6. The functional roles of XTP6 were further elucidated through both in vitro and in vivo experimental approaches. To estimate the interaction between XTP6 and NDH2, RNA pulldown and RNA Immunoprecipitation (RIP) assays were conducted. The connection between XTP6 and the IκBα promoter was examined using Chromatin Isolation by RNA Purification (ChIRP) assays. Additionally, Chromatin Immunoprecipitation (ChIP) assays were implemented to analyze the binding affinity of c-myc to the XTP6 promoter, providing insights into the regulatory mechanisms at play. Results: XTP6 was remarkedly upregulated in glioblastoma multiforme (GBM) tissues and was connected with adverse prognosis in GBM patients. Our investigations revealed that XTP6 can facilitate the malignant progression of GBM both in vitro and in vivo. Additionally, XTP6 downregulated IκBα expression by recruiting NDH2 to the IκBα promoter, which resulted in elevated levels of H3K27me3, thereby reducing the transcriptional activity of IκBα. Moreover, the progression of GBM was further driven by the c-myc-mediated upregulation of XTP6, establishing a positive feedback loop with IκBα that perpetuated the activation of the NF-κB signaling pathway. Notably, the application of an inhibitor targeting the NF-κB signaling pathway effectively inhibited the continuous activation induced by XTP6, leading to a significant reduction in tumor formation in vivo. Conclusion: The results reveal that XTP6 unveils an innovative epigenetic mechanism instrumental in the sustained activation of the NF-κB signaling pathway, suggesting a promising therapeutic target for the treatment of GBM.

TBX15 facilitates malignant progression of glioma by transcriptional activation of TXDNC5

The overexpression and clinical significance of TBX15 in human gliomas

ZNF395 Facilitates Macrophage Polarization and Impacts the Prognosis of Glioma.

TNC Upregulation Promotes Glioma Tumourigenesis Through TDG-mediated Active DNA Demethylation

SOX9+ malignant cells define a poor prognosis subtype of Glioma with tumor-associated macrophage recruitment

SOX15 Exerts Antitumor Function in Glioma by Inhibiting Cell Proliferation and Invasion Via Downregulation of Wnt/β-catenin Signaling.

High Expression of TXNDC11 Indicated Unfavorable Prognosis of Glioma.

DTX2 Promotes Glioma Development Via Regulation of HLTF

Positive feedback loop of c-myc/XTP6/NDH2/NF-κB to promote malignant progression in glioblastoma

RNA-binding protein DHX9 promotes glioma growth and tumor-associated macrophages infiltration via TCF12

A Novel Indication of Thioredoxin-Interacting Protein As A Tumor Suppressor Gene in Malignant Glioma

ZNF436 Promotes Tumor Cell Proliferation Through Transcriptional Activation of BCL10 in Glioma.

TGF-β Signaling Promotes Glioma Progression Through Stabilizing Sox9

Expression of TXLNA in brain gliomas and its clinical significance: a bioinformatics analysis

CXCL5 promotes tumorigenesis and angiogenesis of glioblastoma via JAK-STAT/NF-b signaling pathways

Truncated TEAD-binding Protein of TAZ Inhibits Glioma Survival Through the Induction of Apoptosis and Repression of Epithelial-Mesenchymal Transition.

CXCL5 promotes tumorigenesis and angiogenesis of glioblastoma via JAK-STAT/NF-κb signaling pathways

ZDHHC15 promotes glioma malignancy and acts as a novel prognostic biomarker for patients with glioma

HOXC10 Promotes Proliferation and Invasion and Induces Immunosuppressive Gene Expression in Glioma

The Transcription Factor ZNF148 Promotes the Malignant Transformation of Dendritic Cells after Cross-Talk with Glioma Stem Cells by Upregulating PTX3

CXCL5 promotes the proliferation and migration of glioma cells in autocrine- and paracrine-dependent manners.